Similar to the PHI test in that it uses different PSA‐based markers, the 4 K score differs by also introducing other patient characteristics such as age, results of a digital rectal examination and any prior biopsy history, and combining all factors to create an algorithm to determine if there is any risk of prostate cancer of clinical significance [140]. This evidence concerns the gene PROS1 and prostate cancer.